TRPV6 Calcium Channel Inhibitor SOR-C13

Known as: SOR-C13 
An inhibitor of transient receptor potential cation channel vanilloid family member 6 (TRPV6, CaT1 or CATL) with potential antineoplastic activity… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
01220042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Introduction This was an open-label, dose escalation (3 + 3 design), Phase I study of SOR-C13 in patients with advanced tumors of… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2017
2017
The article First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors… (More)
Is this relevant?
2012
2012
We report on the fabrication of N,N'-ditridecyl-perylene-3,4:9,10-tetracarboxylic diimide-C13 (PTCDI-C13), n-channel organic thin… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Volatile terpenoid compounds, potentially derived from carotenoids, are important components of flavor and aroma in many fruits… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 6
Is this relevant?